MENU

HALO Halozyme Therapeutics Forecast, Technical & Fundamental Analysis

Halozyme Therapeutics Inc is a biotechnology company focused on developing and commercializing novel oncology therapies... Show more

Industry: #Biotechnology
HALO
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
View a ticker or compare two or three
HALO
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I. Advisor
published Earnings

HALO is expected to report earnings to fall 1.32% to $2.25 per share on November 09

Halozyme Therapeutics HALO Stock Earnings Reports
Q3'26
Est.
$2.25
Q2'26
Beat
by $0.47
Q1'26
Beat
by $0.06
Q4'25
Missed
by $2.14
Q3'25
Beat
by $0.11
The last earnings report on August 06 showed earnings per share of $2.28, beating the estimate of $1.81. With 831.18K shares outstanding, the current market capitalization sits at 12.81B.
A.I. Advisor
published General Information

General Information

a developer of recombinant human enzymes for the infertility, ophthalmology and oncology markets

Industry Biotechnology

Industry
Biotechnology
Address
12390 El Camino Real
Phone
+1 858 794-8889
Employees
423
Web
https://www.halozyme.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
CCXIU12.500.23
+1.87%
Churchill Capital Corp XI
ZION62.65N/A
N/A
Zions Bancorporation NA
NVCR15.92-0.03
-0.19%
NovoCure Limited
WSBF19.51-0.15
-0.76%
Waterstone Financial
SORA2.36-0.02
-0.84%
AsiaStrategy

HALO and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, HALO has been loosely correlated with AXON. These tickers have moved in lockstep 47% of the time. This A.I.-generated data suggests there is some statistical probability that if HALO jumps, then AXON could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To HALO
1D Price
Change %
HALO100%
-3.13%
AXON - HALO
47%
Loosely correlated
-0.07%
INCY - HALO
40%
Loosely correlated
-3.47%
GMAB - HALO
38%
Loosely correlated
-3.15%
VRTX - HALO
37%
Loosely correlated
-3.07%
ONC - HALO
36%
Loosely correlated
-1.96%
More
Halozyme Therapeutics (HALO) stock Forecast, Price Targets and Analysts Predictions - Tickeron.com